Related Experiment Video
Updated: Dec 6, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
CYP-associated drug-drug interactions: A mission accomplished?
Olavi Pelkonen1, Jukka Hakkola2,3,4, Janne Hukkanen3,5
1Research Unit of Biomedicine, Pharmacology and Toxicology, University of Oulu, Aapistie 5 B (POB5000), N90014, Oulu, Finland. olavi.pelkonen@oulu.fi.
Abstract:
On the basis of official Finnish Medicines Authority (Fimea)-approved drug monographs, less than half of the approved small-molecule drugs between 2007 and 2016 were substrates, inhibitors or inducers of CYP enzymes, predominantly of CYP3A4. No significant unexpected, life-threatening, CYP-associated drug-drug interactions (CYP-DDIs) of newly approved drug entities have been observed in the last 10-15 years. The present analysis seems to suggest that tools to study and predict potentially significant CYP-DDIs are working and efficient.
More Related Videos
Related Concept Videos
Pharmacokinetics: Drug–Drug Interactions
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

